doi: 10.1016/s0090-4295(96)00010-6
When cells become damaged and are replaced their DNA/RNA degrade into purine molecules which are then metabolized into uric acid
Observational sources report tolerability, but rigorous trials in pregnancy are minimal
Published clinical trials on injectable skin outcomes are limited
The new framework represents an important shift in how innovative therapies are assessed, strengthening collaboration between EU Member States through Joint Clinical Assessments while placing greater emphasis on outcomes that matter to patients and healthcare systems
Hoffman La Roche, Kailera, Lexicon, Lilly USA, Metsera, Neurotronic, Novartis, Novo Nordisk and Zealand